NIO.TO News 0.15 Niocan Inc J (NIO.TO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Niocan Inc J (NIO.TO) 0.15 $NIO.TO

Niocan Issues Statement in Response to TSX Delisting Review
Marketwire - Fri Apr 11, 8:04AM CDT
Niocan Inc. (the "Company" (TSX: NIO) has received notice of from the Toronto Stock Exchange (the "TSX" stating that the TSX is currently reviewing the eligibility of the Company for continued listing of its securities on the TSX. Specifically, the TSX is evaluating the Company with respect to the following two requirements: (i) the minimum expenditures on exploration and/or development work, and (ii) the minimum market value of publicly "freely-tradable" shares (collectively, the "TSX Requirements".

TSX Delisting Review - Niocan Inc. (Symbol: NIO)
CNW Group - Wed Apr 09, 7:00AM CDT
DELISTING REVIEW Niocan Inc. (the "Company" - TSX is reviewing the common shares (Symbol: NIO) of the Company with respect to meeting the continued listing requirements. The Company has been granted 120 days in which to regain compliance with these requirements, pursuant to the Remedial Review Process.

Niocan Inc. Announces Resignation of Director
Marketwire - Tue Nov 12, 8:05AM CST
Niocan Inc. (the "Corporation" (TSX: NIO) announced today that Mr. Terence Ortslan has resigned as Director of the Corporation.

Niocan Inc. Announces Change of Chief Financial Officer
Marketwire - Fri Jul 26, 3:46PM CDT
Niocan Inc. (the "Corporation" (TSX: NIO) announced today that Mr. Ron Amstutz has resigned as Chief Financial Officer of the Corporation and that he will be replaced by Mr. Bruno Dumais, CPA, CA, who will assume this position on August 6, 2013.

Niocan Inc. Announces Voting Results from its 2013 Annual Meeting of Shareholders
Marketwire - Wed Jun 12, 7:39AM CDT
Niocan Inc. (the "Corporation" (TSX: NIO) is pleased to announce the voting results from its annual meeting of shareholders held on June 11, 2013 (the "Meeting".

Niocan's Shares Remain Listed on the TSX
Marketwire - Fri Mar 01, 9:16AM CST
Niocan Inc. ("Niocan" or the "Company" (TSX: NIO) announced today that its common shares will remain listed on the TSX. Niocan was advised by the TSX that the TSX has completed its review of the common shares of the Company and that it has determined that Niocan meets the TSX's continued listing requirements.

Niocan Completes the Conversion of its Debentures
Marketwire - Thu Feb 28, 8:35AM CST
Niocan Inc. ("Niocan" (TSX: NIO) announced today that it has completed the previously announced conversion of the Secured Debentures Series 2011-I dated August 29, 2011 as amended on August 29, 2012 (the "Debentures". The Debentures, which bore the principal amount of $3,005,000, have been converted into 2,176,035 common shares in the capital of Niocan.

TSX DELISTING REVIEW - Niocan Inc. (Symbol: NIO)
CNW Group - Mon Jan 28, 7:45AM CST
DELISTING REVIEW Niocan Inc. (the "Company" - Further to TSX Bulletin 2012-1031 dated September 24, 2012, TSX has extended its review of the eligibility of the Common Shares (Symbol: NIO) of the Company for continued listing for a period of 30 days.

Niocan Advances the Date of Conversion of its Debentures
Marketwire - Thu Jan 10, 3:59PM CST
Niocan Inc. ("Niocan" or the "Company" (TSX: NIO) announced today that it has decided to advance the date of conversion of the Secured Debentures Series 2011-I dated August 29, 2011 as amended on August 29, 2012 (the "Debentures" from the previously-announced date of March 31, 2013 to February 28, 2013. The Debentures will be converted into common shares in the capital of Niocan, subject to the terms of the Debentures and any applicable regulatory or stock exchange approval. The Debentures bear a principal amount of $3,005,000.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading